Clinical Trial Update: Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Pakistan evaluating adenosine pre-medication during primary percutaneous coronary intervention in STEMI patients to reduce no-reflow, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon | Phase 4 | Status: RECRUITING